Podcasts about aanp

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/psychiatric-therapeutics-in-a-digital-world-10096SummaryIn this PsychTalk podcast/webcast episode, Drs. Gregory Mattingly and Lisa Harding delve into the digital world and breakdown its effects on mental health—both positive and negative. By the end of the episode, learners will have a better understanding of the relationship between screen time, social media, and attention, including clinical pearls for how to harness prescription technology to enhance patient outcomes in ADHD and depression.This podcast was recorded and is being used with permission of the presenters.Learning ObjectivesAt the conclusion of this activity, participants should be better able to:Examine the relationship between social media and attentionIncorporate FDA-authorized digital therapeutics into ADHD and depression management plans based on current clinical evidenceThis activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which does not include hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is not commercially supported.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/clinical-updates-in-schizophrenia-10097SummaryIn this PsychTalk podcast/webcast episode, Drs. Gregory Mattingly and Lisa Harding go through the evolving landscape of schizophrenia treatments. Listen as they discuss the pros and cons of various second-generation antipsychotics, the science behind muscarinic modulation for psychosis, and recent updates in clozapine prescribing. At the end of the session, the doctors answer several audience questions to enhance your understanding of these developments and how they apply to clinical practice.This podcast was recorded and is being used with permission of the presenters.Learning ObjectivesAt the conclusion of this activity, participants should be better able to:Integrate recent clinical data on antipsychotic treatments and relapse prevention strategies into management plans for patients with schizophreniaDescribe the role of muscarinic modulation in psychosisThis activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which includes 0.75 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is not commercially supported.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Credits: 0.50 AMA PRA Category 1 Credits™, 0.50 ABIM MOC or 0.52 AANP including 0.52 AANP Pharm   CME/CE Information and Claim Credit: https://www.pri-med.com/online-cme-ce/Podcast/post-exposure-prophylaxis-covid-19  Overview: Explore the evolving role of post-exposure prophylaxis (PEP) for COVID-19 in high-risk populations. Join infectious disease experts from Johns Hopkins as they discuss the latest data, clinical considerations, and promising agents in reducing severe outcomes when vaccination alone may not be enough. 

In this second episode of a three-part series, Drs. Ruth Carrico and Paula Tucker explore the challenges of medical misinformation, its impact on patient care and strategies for navigating the overwhelming flow of health information in today's digital age. The discussion covers the rise of the "infodemic” how misinformation spreads and how nurse practitioners (NPs) can critically evaluate medical literature to ensure evidence-based practice. The hosts share real-world experiences from the COVID-19 pandemic, highlighting the difficulties of adapting to rapidly evolving guidelines while maintaining public trust. They also discuss the role of social determinants of health in the spread of misinformation and provide practical solutions for mitigating misinformation in clinical settings. Key Takeaways: Understanding the Infodemic: Definition: An overload of health-related information — both accurate and inaccurate — spread rapidly via social media, news and professional circles. Impact of COVID-19: Misinformation amplified due to evolving scientific knowledge, political influences and social media algorithms. Role of Trust: Public mistrust in health care institutions and shifting guidelines fueled skepticism. Misinformation Drivers and Consequences: Psychological Factors: Cognitive biases (confirmation bias, authority bias) make individuals more susceptible to misinformation. Technology and Social Media: Algorithm-driven content creates echo chambers where misinformation spreads unchecked. Public Health Outcomes: Misinformation leads to vaccine hesitancy, delayed treatments and preventable deaths. How NPs Can Combat Misinformation: 1. Active Listening: Understand patients' concerns before correcting misinformation. 2. Effective Communication: Use simple, culturally relevant messaging tailored to health literacy levels. 3. Building Resilience: Teach patients how to critically evaluate health information sources. 4. Community Engagement: Collaborate with local leaders and organizations to promote credible information. Evaluating Evidence-Based Information: Use the CRAAP Test (Currency, Relevance, Authority, Accuracy, Purpose) to assess credibility. Trust peer-reviewed sources like CDC, WHO, FDA, Cochrane Reviews and PubMed. Be aware of misleading studies and cherry-picked data used to spread misinformation. Trusted Resources for Patients and Providers: For Clinicians: UpToDate, DynaMed, BMJ Best Practice, Cochrane Reviews. For Patients: MedlinePlus, Mayo Clinic, CDC Vaccine Fact Sheets, American Heart Association. To claim 1.1 contact hours (CH) of continuing education (CE) credit for this program, “Navigating the Infodemic: A Call for Critical Thinking to Optimize Patient Care,” search for this program by the title and complete the posttest and evaluation by entering the participation code provided after listening to the podcast. “This activity is sponsored by an independent medical education grant from Kenvue.” Tool: https://www.aanp.org/practice/clinical-resources-for-nps/clinical-resources-by-therapeutic-area/primary-care Next Episode Preview: In the final episode of this series, Drs. Carrico and Tucker will dive into practical strategies for debunking medical myths, patient-centered communication techniques and choosing the right battles when addressing misinformation.

Are you preparing for your NP board certification exam and feeling overwhelmed by professional role practice questions? These questions make up a significant portion of the ANCC exam and even appear on the AANP test. So today, I'm breaking down exactly what you need to know about the professional role of nurse practitioners to succeed on your boards and in clinical practice.   Get full show notes, transcript, and more information here: https://blog.npreviews.com/professional-role-questions-np-board-exams

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/characterizing-connected-conditions-in-psychiatry-10045SummaryIn this PsychTalk podcast/webcast episode, Drs. Gregory Mattingly and Lisa Harding discuss some of the complexities of mental health care: overlapping symptoms and differential diagnoses. Listeners will learn about the connections between certain psychiatric disorders and how symptom combinations may influence treatment and patient outcomes. The program will also review strategies to help with accurate diagnoses in complex patient presentations, teaching listeners how to take a thorough patient history and use that information to guide treatment decisions.This podcast was recorded and is being used with permission of the presenters.Learning ObjectivesAt the conclusion of this activity, participants should be better able to:Describe the impact of comorbid mental health diagnoses on patient outcomesEmploy strategies to aid in the differential diagnosis of patients who present with symptoms suggestive of multiple mental health conditionsThis activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which does not include hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is not commercially supported.Send us a text about this episode. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/practical-management-for-complex-psychiatric-cases-10046SummaryIn this PsychTalk podcast/webcast episode, Drs. Gregory Mattingly and Lisa Harding teach by case example. Listeners will hear an introduction to a complex patient presentation and then be taken through expert strategies to discern the correct diagnoses. The program will conclude with the same case example to tie together the education and demonstrate these strategies in practice.This podcast was recorded and is being used with permission of the presenters.Learning ObjectiveAt the conclusion of this activity, participants should be better able to:Apply evidence-based strategies to develop personalized treatment plans when managing patients with comorbid mental health disordersThis activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which does not include hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is not commercially supported.Send us a text about this episode. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

In this episode of the Functional Nurse Podcast, host Brigitte Sager DNP shares insights from the AANP Health Policy Conference, emphasizing the importance of nurse practitioners in advocating for healthcare policy changes. She discusses the challenges faced by nurse practitioners, particularly in rural areas, and highlights key statistics about their impact on patient care. The conversation also covers the need for better representation and advocacy within the nursing profession, as well as the importance of addressing misinformation and funding for nursing initiatives.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/exercise-for-mental-health-9983SummaryWe've heard it time and time again, exercise is of great importance to our physical health—but did you know it is also important to our mental health? An activity as simple as taking a daily walk can have a substantial positive impact on depression outcomes. Despite the widespread benefits of exercise, patients and providers may overlook its importance in treatment plans. This presentation focuses on the mental and physical benefits of exercise, drawing insights from published data and clinical experience.In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Gerald Maguire discuss the benefits of exercise on both physical and mental health. Throughout the episode, they go through the research that supports the benefits of exercise, as well as provide practical strategies to encourage your patients to adopt exercise into their lifestyles.This podcast was recorded and is being used with permission of the presenters.Learning ObjectivesAt the conclusion of this activity, participants should be better able to:Describe the impact of exercise on mental healthReview data from prospective studies investigating the relationship between exercise and depressionThis activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which does not include hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is not commercially supported.Send us a text about this episode. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/psychedelics-for-depression-9984SummaryIn this PsychTalk podcast/webcast episode, Drs. Gregory Mattingly and Gerald Maguire explore the emerging role of psychedelics in treating mental health conditions. Listeners will learn about the mechanisms of action of psychedelic therapeutics and gain insights into their effects on the brain and behavior. The program will also review recent clinical trial data on the efficacy of psychedelic treatments for major depressive disorder (MDD), as well as provide expert insights on how to discuss the future of psychedelics with patients.This podcast was recorded and is being used with permission of the presenters.Learning ObjectivesAt the conclusion of this activity, participants should be better able to:Describe the mechanism of action of psychedelic therapeuticsReview clinical trial data regarding the use of psychedelic treatments in MDDThis activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which includes 0.75 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is not commercially supported.Send us a text about this episode. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Peptides have been gaining attention in the medical world, but what are they, and can they truly help with healing? In this episode, Dr. Brian Trainor shares his personal journey from being a competitive athlete and Army officer to dealing with multiple severe injuries, including ulcerative colitis, head trauma, and a fractured femur. His experience with conventional medicine left him searching for better solutions, leading him to functional medicine and ultimately, peptide therapy.Dr. Trainor explains the science behind peptides, how they differ from hormones and supplements, and why they are gaining traction in regenerative medicine. He discusses the safety of peptide therapy, the misconceptions surrounding it, and how they can help with inflammation, gut health, and cellular communication. Additionally, we explore how peptide therapy intersects with faith and the body's natural ability to heal, making this an insightful conversation for those looking for alternative approaches to health and wellness.If you're considering peptide therapy or want to learn more about its benefits, Dr. Trainor provides valuable insights into sourcing high-quality peptides, understanding dosing, and using them in conjunction with lifestyle changes. Tune in to hear how this innovative therapy could be a game-changer for your health.Highlights:Dr. Brian Trainor's personal health journey from severe injuries to healingThe role of peptides in gut health, inflammation, and recoveryDifferences between peptides, hormones, and other supplementsMisconceptions about peptide therapy and its safetyHow peptides interact with the body's natural healing mechanismsThe intersection of faith, medicine, and alternative healing methodsPractical tips for those considering peptide therapyThe importance of personalized health approachesHow to source quality peptides and avoid low-quality productsThe future of peptide therapy in functional and regenerative medicineResources MentionedTrinity Naturopathic Website | trinity-naturopathic.comLinkedIn | www.linkedin.com/in/brian-trainor2Instagram | @dr.trainorTikTok | @drtrainorAbout the Guest:While serving as an Army officer, Dr. Trainor faced multiple health challenges, including a fractured femur, a traumatic brain injury, and an autoimmune diagnosis of ulcerative colitis. These obstacles led him to search for approaches beyond conventional medicine. Dr Trainor met a Naturopathic Doctor outside of the military medical system that was able to help him begin his healing journey.As his own health has improved, he has become passionate about helping others diagnosed with autoimmune conditions, and other military members or veterans diagnosed with unseen illnesses. Dr. Trainor aims to offer others the same hope that Naturopathic medicine has offered him.Brian is a 2020 graduate of Bastyr University California. In his final year of school, Brian served as the Naturopathic Medical Student Association (NMSA) President. He was also named NMSA Public Policy Fellow, and through this helped to lead the AANP's Task Force for Veterans affairs and has volunteered as a Whole Health Facilitator for veterans at the San Diego VA hospital. Brian is active in a faith-based organization called the Navigators.

This year, AANP celebrates its 40th anniversary. What began as an idea sprouted under an apple tree in Jan Towers' backyard has become an organization representing the interests of more than 385,000 licensed NPs in the country. Sharing their reminiscences of AANP and the NP role from the 80s until today are a group of NPs pivotal in the history of AANP — Elayne DeSimone, Richard Ricciardi, Kim Curry and Stephen Ferrara — who speak about their contributions to AANP and what they hope the future holds for all NPs. 

In this episode of Fill Me In, Jon and Nicole welcome special guest Megan Piersanti, a nurse practitioner specializing in wellness programs.Megan shares her journey into the world of wellness and discusses the intricate connections between aesthetics and overall health. The conversation dives deep into topics such as hormone therapy, metabolic plans, weight management, the benefits and intricacies of peptides like GLP-1 and NAD, comprehensive blood work, thyroid and vitamin testing, and the potential impact of lifestyle factors such as diet and environmental exposures on health. The episode is filled with insights on optimizing health, education on science-backed treatments, and practical advice for both men and women to achieve their wellness goals. Whether you're interested in aesthetics, wellness, or general health, this episode offers valuable information and actionable tips.Megan Piersanti APN, FNP-C: Megan obtained her Doctorate (2021) & Bachelor of Nursing (2015) from Rutgers University and is a certified by the AANP as a Family Nurse Practitioner. She is the clinical lead of Exhibit Wellness and offers weight management, hormone optimization, and lifestyle management services. Her clinical background in cardiac and emergency medicine has provided a wealth of knowledge regarding health promotion across the lifespan. She has 2 young daughters, and a husband also in the healthcare industry, who have collectively inspired her passion of preventative care and wellbeing.Book an appointment with Megan: https://exhibitmedicalaesthetics.com/Follow Megan on Instagram: https://www.instagram.com/megaesthetic_apn/On Fill Me In: An Aesthetics Podcast, Jon LeSuer NP-C and Nicole Bauer FNP-BC dive deep in the world of aesthetics. As aesthetic nurse practitioners with their own medical practices, Jon and Nicole fill you in on everything in their field.Follow Fill Me In on Instagram!https://www.instagram.com/thefillmeinpod/Follow Nicole on Instagram:https://www.instagram.com/aestheticnursenicole/Follow Jon on Instagram:https://www.instagram.com/injectorjon/Exhibit Medical Aesthetics website:https://exhibitmedicalaesthetics.com/Tox and Pout Aesthetics website:https://toxandpout.com/Producer of Fill Me In: Joseph Ginexi

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/breakthroughs-of-mental-health-advances-9942SummaryWe saw a lot of changes in 2024, especially in the mental health/psychiatry space. Keeping up with the most current information and how it affects your practice can be challenging in this ever-changing landscape. This presentation aims to make this information more accessible to clinicians so that patients can receive the most up-to-date care.In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Gerald Maguire wrap up 2024 with a question-and-answer session focused on the latest advances in the mental health field. Listen as they go through questions covering major depressive disorder, ADHD, bipolar disorder, and schizophrenia.This podcast was recorded and is being used with permission of the presenters.Learning ObjectiveAt the conclusion of this activity, participants should be better able to:Review the latest advances in ADHD, MDD, bipolar disorder, and schizophreniaThis activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which includes 0.50 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is not commercially supported.Send us a text about this episode. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/tick-tock-psych-expert-tips-on-complex-patient-management-9943SummaryMore often than not, patients present to clinicians with multiple diagnoses—complicating treatment decisions. Whether the comorbidities are related to psychiatric, cardiovascular, or neurologic etiologies, psychiatry clinicians need to know how to optimally manage patients in the face of such challenges. This presentation provides quick, to-the-point answers to audience questions regarding complex patient management.In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Gerald Maguire go against the clock to answer your questions on complex patient management in the psychiatry setting. They are given 2 minutes to answer each question, packing their expertise into small, bite-sized sections.This podcast was recorded and is being used with permission of the presenters.Learning ObjectiveAt the conclusion of this activity, participants should be better able to:Discuss psychiatric management considerations for patients with complex comorbidities in your clinical practice.This activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which includes 0.25 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is not commercially supported.Send us a text about this episode. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

In this episode of the Business of Aesthetics podcast, host Michael Walker sits down with Deborah Quinn, an AANP-certified family nurse practitioner with dual certification in dermatology. Deborah brings over 25 years of nursing experience and 16 years specializing in medical, surgical, and cosmetic dermatology. As the founder of Clarity Acne and Aesthetic Dermatology in Suffolk, Virginia, Deborah has built a niche practice dedicated to treating acne and facial aesthetics. Aesthetic professionals cannot afford to miss this episode! Deborah shares insights on integrating evidence-based dermatology with cutting-edge aesthetic treatments, emphasizing a holistic and personalized approach. From enhancing patient confidence to leveraging innovative business strategies like "Walk-In Wednesdays" and "Medical Mondays," listeners will gain practical advice on building a thriving, patient-centered practice. Key takeaways include tips for maintaining a focused practice, the importance of gut-brain-skin health, and ways to balance medical dermatology with aesthetics. Whether you're just starting in aesthetics or a seasoned professional, this episode will inspire and equip you with strategies to stand out in a competitive industry.

 In the last episode, you heard some of my testimony at the Texas Interim Legislature hearing on Scope of Practice. Today you're going to hear from a nurse practitioner, Holly Jeffries, who is practicing in rural Texas.Her testimony was particularly impactful and really quite persuasive to legislators. I think it's important to understand the NP point of view and also learn the concerns of legislators by listening to their line of questioning.Referenced in the podcast:Facts about NP primary care numbers (HRSA shows much fewer doing primary care than AANP represents): https://youtu.be/AqyUdQZ-9fYSupervising physicians sued without ever seeing or being consulted on a patient: https://www.medscape.com/viewarticle/990494?form=fpfhttps://youtu.be/GlfPSnHgC1Ahttps://www.jucm.com/supervising-doctors-may-be-held-liable-in-malpractice-suits/https://www.medpagetoday.com/meetingcoverage/acep/106708Increasing rates of malpractice and adverse reports for NPs: https://youtu.be/EOeGhR2uUSUPhysiciansForPatientProtection.org

Credits: 0.50 AMA PRA Category 1 Credit™, 0.50 ABIM MOC or 0.41 AANP, including 0.41 AANP Pharm   CME/CE Information and Claim Credit: https://www.pri-med.com/online-cme-ce/Podcast/when-ssris-are-not-enough  Overview: In this podcast, expert faculty will discuss how the heterogeneity of major depressive disorder (MDD) symptoms, the frequency of residual symptoms, and the common occurrence of treatment-resistant depression (TRD) indicate a pathophysiology that is complex and multifactorial. The faculty will provide an overview of the current understanding of MDD pathophysiology and discuss how current standard-of-care treatments often fail to comprehensively target these mechanisms, emphasizing how future treatment developments can focus on under-addressed pathophysiological mechanisms, paving the way for personalized MDD treatments that target individual symptom profiles. 

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/adult-adhd-diagnosis-and-management-9854SummaryAdult ADHD is a neurodevelopmental disorder that often persists from childhood into adulthood, affecting attention, impulsivity, and executive function. Despite increased awareness, ADHD in adults remains underdiagnosed and undertreated, presenting unique challenges in clinical practice. This presentation focuses on strategies to address these challenges, drawing insights from recent data and provides our experts recommendations.In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Vladimir Maletic discuss key findings from the CDC report on adult ADHD, including trends in prevalence, diagnostic gaps, and barriers to effective treatment. They also explore the latest research on gender differences in ADHD, emphasizing how these disparities impact diagnosis and treatment approaches. Our experts highlight the need for tailored strategies to ensure more accurate and effective care, especially given that women are often diagnosed later in life and may experience different symptom presentations than men.This podcast was recorded and is being used with permission of the presenters.Learning ObjectivesAt the conclusion of this activity, participants should be better able to:Review key insights from the CDC report regarding the prevalence, diagnosis trends, and treatment challenges of ADHD in adultsExamine the latest data on gender differences in ADHD diagnosis and treatmentThis activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which does not include hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is not commercially supported.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Making the Case for Long-Acting Reversible Contraception (CE) Long-acting reversible contraception (LARC) is a very effective means of preventing an unintended pregnancy. The CDC recommends that clinicians provide patients with information about the effectiveness of all contraceptive options that they are medically eligible for. However, primary care providers and nurse practitioners report discussing LARC in less than half of their contraceptive counseling encounters. On today's episode, nurse practitioners Barb Dehn and Dr. Joan Zaccardi discuss the vital role of the NP in contraceptive counseling and the importance of including LARC as a contraceptive option. A participation code will be provided at the END of the podcast – make sure to write this code down. One you have listened to the podcast and have the participation code, return to this activity in the CE Center. Click on the "Next Steps" button of the activity and Enter the participation code that was provided Complete the post-test Complete the activity evaluation This will award your CE credit and certificate of completion. 0.75 CE, 0.5 RX, will be available through December 31, 2025.   This activity is partially supported by an educational grant from CooperSurgical. The remainder is funded by AANP. Resources: U.S. Selected Practice Recommendations for Contraceptive Use, 2024 (cdc.gov)

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/questions-and-answers-on-amyloid-cardiomyopathy-and-polyneuropathy-9845SummaryIn this activity – which learners can review as a podcast or a webcast - Drs. Chafic Karam and Michelle Kittleson dive into five key questions from recent live-virtual broadcasts about transthyretin amyloidosis (ATTR). They discuss the role of cardiac MRI, biopsy, and genetic testing in diagnosing ATTR cardiomyopathy and polyneuropathy. They also explore treatment options, including silencing therapies and stabilizers, with insights into when patients should be referred for specialized care. The conversation emphasizes the importance of early diagnosis, collaborative care between neurologists and cardiologists, and the expanding therapeutic landscape for ATTR.Learning ObjectivesAt the conclusion of this activity, participants should be better able to:Describe the correct diagnostic algorithm for suspected ATTR, including interpretation of the monoclonal protein screen and indications for biopsy and genetic testing.Initiate appropriate management, including disease-directed therapy and appropriate cardiac care, or referral when indicated.This activity is accredited for CME/CE CreditAssociation of Black Cardiologists, Inc. (ABC) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.Association of Black Cardiologists, Inc. designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and ABC. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.25 contact hours (which does not include hours of pharmacology).In support of improving patient care, this activity has been planned and implemented by Haymarket Medical Education (HME) and NACE. Haymarket Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.This knowledge-based activity JA4008232-9999-24-043-H01-P qualifies for 0.25 contact hours (0.025 CEUs) of continuing pharmacy education credits.For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is supported by an educational grant from Alnylam Pharmaceuticals, Inc., and an educational grant from AstraZeneca Pharmaceuticals.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/streamlined-strategies-for-managing-tardive-dyskinesia-9842SummaryTardive dyskinesia (TD) is a debilitating movement disorder that manifests as involuntary, repetitive movements, often of the face, tongue, and extremities. These symptoms frequently result from prolonged use of antipsychotic medications, particularly in patients being treated for schizophrenia, bipolar disorder, or major depressive disorder. Accurate and routine assessment of TD is critical to prevent symptom progression and improve patient outcomes. The Abnormal Involuntary Movement Scale (AIMS) is a widely accepted, gold-standard tool used to detect and measure the severity of involuntary movements. AIMS enables clinicians to detect involuntary movements early and track the disorder's progression, facilitating timely intervention and individualized treatment plans.In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Vladimir Maletic delve into the complexities of diagnosing and managing tardive dyskinesia (TD), emphasizing evidence-based strategies to improve patient outcomes. They discuss the importance of using the Abnormal Involuntary Movement Scale (AIMS), a standardized and validated tool, for regular TD assessment. AIMS enables clinicians to detect involuntary movements early and track the disorder's progression, facilitating timely intervention and individualized treatment plans.Learning ObjectiveAt the conclusion of this activity, participants should be better able to:Explore strategies to simplify management and optimally improve outcomes for patients with TDThis activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which includes 0.50 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is supported by an educational grant from Neurocrine Biosciences.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/leaky-gut-leaky-brain-addressing-gut-brain-axis-9815SummaryThough it is widely acknowledged that the gut is our largest endocrine and immune organ, its role in brain health is less well-known. When is the last time you asked a patient with depression about their diet? Mental health care expands beyond pharmacologic treatment, as explained in this activity detailing the influence of the gut-brain axis on neuroinflammation and the role that diet and pre/probiotics can play in mental health treatment.In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Vladimir Maletic discuss the gut-brain axis and its influence on brain health, from its role in the manifestation of certain brain disorders and how we can target the gut to ultimately improve patient outcomes in psychiatry.This podcast was recorded and is being used with permission of the presenters.Learning ObjectivesAt the conclusion of this activity, participants should be better able to:Identify the key mechanisms of the gut-brain axis influence on brain disorders.Discuss ways of incorporating understanding of gut dysbiosis into comprehensive treatment of psychiatric disorders.This activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which does not include hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is not commercially funded.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/management-of-amyloid-cardiomyopathy-and-polyneuropathy-9813SummaryIn this CME/CE podcast episode, Cardiologist Dr. Michelle Kittleson and Neurologist Dr. Chafic Karam discuss the multidisciplinary management of transthyretin amyloidosis (ATTR). They explore how ATTR affects both the heart and the nervous system, focusing on recognizing symptoms, diagnosing the disease, and managing treatment. Dr. Karam shares insights on peripheral neuropathy caused by amyloidosis, including clues that suggest amyloidosis over more common neuropathies. Dr. Kittleson highlights how cardiologists assess and manage TTR cardiomyopathy, emphasizing the importance of early diagnosis and the evolving therapeutic landscape. Together, they discuss the collaborative nature of care, the impact of new therapies on clinical outcomes, and the importance of raising awareness for ATTR.Learning ObjectivesDescribe the correct diagnostic algorithm for suspected ATTR, including interpretation of the monoclonal protein screen and indications for biopsy and genetic testingInitiate appropriate management, including disease-directed therapy and appropriate cardiac care, or referral when indicatedThis activity is accredited for CME/CE CreditAssociation of Black Cardiologists, Inc. (ABC) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.Association of Black Cardiologists, Inc. designates this enduring material for a maximum of 0.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and ABC. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.25 contact hours (which does not include hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is supported by an educational grant from Alnylam Pharmaceuticals Inc., and an educational grant from AstraZeneca Pharmaceuticals.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Hear from the Director of Federal Advocacy for the American Association of Nurse Practitioners (AANP) about the Increasing Access to Quality Cardiac Rehabilitation Care Act of 2023.Jessica walks listeners through the importance of this bill, how it expands upon the previously approved Cardiac Rehab Bill (in 2018), and why it is important for our patients.CDC Million Hearts: https://millionhearts.hhs.gov/index.htmlNurse Practitioners: A Solution to America's Primary Care Crisis Study: https://www.aei.org/research-products/report/nurse-practitioners-a-solution-to-americas-primary-care-crisis/cMedPAC Health Care Spending and the Mediare Program Study: https://www.medpac.gov/wp-content/uploads/2024/07/July2024_MedPAC_DataBook_SEC.pdfAANP Action Center for Cardiac Rehab: https://www.votervoice.net/AANP/1/Campaigns/104006/RespondPCNA Advocacy Training Course: https://pcna.net/online-course/from-care-to-action-basics-of-nurse-advocacy/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/vmat2-inhibitors-in-tardive-dyskinesia-9799SummaryTardive dyskinesia (TD) is a syndrome characterized by various iatrogenic movement disorders resulting from dopamine receptor antagonism. These movement disorders include akathisia, dystonia, buccolingual stereotypy, chorea, tics, and other abnormal involuntary movements, most commonly emerging after prolonged antipsychotic use.Vesicular monoamine transporter type 2 (VMAT2) inhibitors are now available in the United States for managing dyskinesia syndromes, each with a slightly different range of approved indications. VMAT2 inhibitors are agents that cause a depletion of neuroactive peptides such as dopamine in nerve terminals and are used to treat chorea due to neurodegenerative diseases or dyskinesias due to neuroleptic medications (tardive dyskinesia).In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Vladimir Maletic discuss the structural and pharmacokinetic differences between these agents, understanding how they modulate dopamine levels at hypersensitive D2 receptors, common in TD. The program emphasizes the importance of VMAT2 inhibition and its interaction with antipsychotic medications.This podcast was recorded and is being used with permission of the presenters.Learning ObjectiveAt the conclusion of this activity, participants should be better able to:Examine the pharmacologic differences between the various VMAT2 inhibitorsThis activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which includes 0.50 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is supported by an educational grant from Neurocrine Biosciences.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/dare-to-move-beyond-symptom-improvement-schizophrenia-9781SummarySchizophrenia is a chronic and debilitating mental illness that significantly affects not only the health, well-being, and functioning of patients but also their surrounding environment. Promoting resilience is essential for enhancing health as well as treating mental health issues. A fresh perspective on schizophrenia emphasizes early intervention, symptom enhancement, relapse prevention, functional advancement, and quality of life improvement. The importance of personalized care to improve functional outcomes for individuals living with the condition gain insights into the DARE approach:Detection – The importance of early detection and intervention in reducing the burden of schizophrenia and increasing recovery chances.Adherence – Shared decision-making for optimal medication choice, focusing on balancing efficacy and minimizing adverse effects that can lead to nonadherence (e.g., sedation, weight gain).Recovery – Functional recovery, quality of life, and achieving personal life goals as key outcomes in treatment.Engagement – Supporting patients in leading purposeful and meaningful lives.In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Vladimir Maletic discuss the DARE approach and how shifting the goals of schizophrenia treatment toward not just response and remission but full recovery and resilience, underscore a holistic approach to mental health.This podcast was recorded and is being used with permission of the presenters.Learning ObjectivesAt the conclusion of this activity, participants should be better able to:Evaluate the latest advancements in functional domains for schizophrenia treatment.Discuss personalized treatment to improve functional outcomes for individuals living with schizophrenia.This activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which does not include hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.DiscloPlease visit http://naceonline.com to engage in more live and on demand CME/CE content.

On this episode of NP Pulse, our guests are the American Association of Nurse Practitioner's® (AANP) Vice President of Research Kate Bradley and research analyst Mitch Sellers, who join host Sophia Thomas to discuss AANP's recently released compensation and practice reports. Together, they explore what kind of information is available in both reports; detail some of the most important findings regarding compensation; and explain why it's important for all nurse practitioners (NPs) to access and use this data. Download the 2024 AANP Practice and Compensation Reports here.

As we approach Medicare's Open Enrollment period, NP Pulse welcomes AANP's president elect Valerie Fuller to discuss the big changes that have happened — and will happen starting Jan. 1 of 2025— to Medicare Part D.  Learn how seniors can opt in to the program and what changes will be taking place with regard to costs for medications, vaccines and more. This podcast is made possible by PhRMA.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/tackling-residual-risk-in-ascvd-and-ckd-9653SummaryInflammation plays a pivotal role in both cardiovascular and chronic kidney disease, making it a crucial target for reducing patient risk. In this focused 15-minute podcast, our experts break down the latest insights into how inflammation drives these conditions and explore innovative approaches to managing it.Listen to Dr. Ridker as he will delve into the critical role of inflammation in cardiovascular and chronic kidney disease, with a focus on the predictive value of hsCRP as a biomarker for ASCVD and CKD risk. Dr. Ridker explores emerging strategies to address inflammation, and how these advancements could potentially reduce cardiovascular risk and improve patient outcomes.Learning ObjectiveAt the conclusion of this activity, participants should be better able to:Recognize the role of hsCRP as a biomarker in evaluating the risk of ASCVD and CKDIdentify the role of current and emerging agents, based on their mechanism of action, to target inflammation and potentially reduce cardiovascular riskThis activity is accredited for CME/CE CreditAssociation of Black Cardiologists, Inc. (ABC) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.Association of Black Cardiologists, Inc. designates this enduring material for a maximum of 0.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and ABC. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which includes 0.25 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is supported by an independent medical educational grant from Novo Nordisk.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Don't miss the Signs: Early Recognition and Management of Tardive Dyskinesia In this episode, Amber Hoberg and Dr. Jennifer Sampang bring us an engaging discussion on the complexities of tardive dyskinesia, the significance of early detection and treatment, and the considerable burden it has on patients. As they unwind the mysteries of TD, we get a better understanding of the importance of being vigilant and proactive in detecting it and keeping our patients informed and involved in their treatment plans. Together, through early recognition, informed discussions, and shared decision-making, we can mitigate the impact of TD and improve the lives of those affected. Additionally, a Tardive Dyskinesia Point-of-Care tool will be available on AANP's Tools and Resources page. To earn 1.0 contact hours of continuing education (CE) credit, you will need the participation code provided at the end of the podcast. To claim your CE credit, log in and register for the activity within the AANP CE Center log in and register for the activity within the AANP CE Center, then enter the participation code and complete the posttest and evaluation. CE credit is available for this podcast through August 2025. This educational activity is supported by an independent medical education grant from Neurocrine Biosciences, Inc.

Did you miss this year's American Association of Naturopathic Physicians Convention? In this interview, Karolyn talks with the organization's president Kasra Pournadeali, ND, FACN, about the mission/vision of the organization, conference highlights, and future directions. In addition to being the AANP President, Pournadeali is the director of the Northwest Center for Optimal Health and on the faculty of Bastyr University.   About the Expert Kasra Pournadeali, ND, FACN, is the founder and director of the Northwest Center for Optimal Health, a primary care residency training facility in Washington State. With over 30 years as a healthcare provider and more than 20 years as a practicing physician, he has been a faculty member at Bastyr University since 1999. Pournadeali serves on the boards of the ACCME-Accredited Foundation for Care Management and the Integrative Health Care Practitioner Consortium. An expert in naturopathic cardiology, insurance coding, and practice management, he has made numerous media appearances and published extensively. Listen to his radio show, Sound Living with the Doctors, Thursdays at 4 PM PST on FM 90.7, FM 89.9, or online at www.kser.org. For more information, visit www.ncoh.net.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/recognizing-the-burden-of-residual-symptoms-in-mdd-9526SummaryEarly and effective treatment of major depressive disorder (MDD) is essential to prevent persistent residual symptoms, which are associated with worse outcomes. Evidence indicates that residual symptoms, such as impaired cognition, are underrecognized and undertreated in routine clinical care. Recognizing residual symptoms and the factors contributing to suboptimal treatment response is a critical first step to modifying management, with the goal of eliminating residual symptoms and achieving full remission.In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Vladimir Maletic discuss common residual symptoms and other signs of suboptimal treatment response, including the impact of antidepressant side effects and the efficacy of antidepressants for residual symptoms.This podcast/webcast was recorded and is being used with permission of the presenters.This activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which includes 0.25 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

On this episode of NP Pulse: The Voice of the Nurse Practitioner®, Drs. Mary Koslap-Petraco and Ruth Carrico will discuss meningococcal disease, the maze of meningococcal vaccines, ACIP recommendations and the use of shared clinical decision-making. Meningococcal disease — a life-threatening infection caused by Neisseria meningitidis — demands our attention. It strikes swiftly, leaving devastation in its wake. Still, we have powerful tools at our disposal: MenACWY and MenB vaccines, and a new, game-changing pentavalent vaccine that covers serogroups A, B, C, W and Y. Additionally, a meningitis point-of-care tool will be available on AANP's Tools and Resources page. To earn 1.0 contact hours of continuing education (CE) credit, you will need the participation code provided at the end of the podcast. To claim your CE credit, log in and register for the activity within the AANP CE Center, then enter the participation code and complete the post-test and evaluation. CE credit is available for this podcast through June 2025. This educational activity is supported by an independent medical education grant from GSK.

Credits: 0.25 AMA PRA Category 1 Credits™, 0.25 ABIM MOC or 0.30 AANP, including 0.30 AANP Pharm   CME/CE Information and Claim Credit: https://www.pri-med.com/online-cme-ce/Podcast/treatment-of-alzheimer-disease  Overview: This podcast will address recent updates in the clinical landscape of Alzheimer disease (AD) treatment and will also include answers to frequently asked questions about the treatment of AD posed by Pri-Med learners. For further education on AD diagnosis and management, the other 3 podcasts in this series can be found here: https://www.pri-med.com/online-cme-ce/curriculum/mind-over-memory  

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/answering-your-questions-on-lipids-and-risk-9498SummaryThere's no shortage of information on the management of lipids for the prevention of cardiovascular disease:2018 Guideline on the Management of Blood Cholesterol.2022 ACC Expert Consensus Decision Pathway.CLEAR Outcomes, CVOT studies, Risk Calculators.Helping sort these and other topics out, Dr. James Underberg and Dr. Jessica Pena discuss the top 5 learner submitted questions/topics from the recent programs on non-statin lipid management in primary prevention of ASCVD.This activity is accredited for CME/CE CreditAssociation of Black Cardiologists, Inc. (ABC) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.Association of Black Cardiologists, Inc. designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and ABC. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.25 contact hours (which includes 0 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is supported in part by an educational grant from Esperion Therapeutics, Inc. and an independent educational grant from Novartis Pharmaceuticals Corporation.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Earlier this year, AANP announced the opening of international memberships — the culmination of years of work to extend the benefits of our membership to NPs and APNs living outside of the U.S. To speak with us today about the creation of international memberships, the benefits of joining AANP as an international member and some of the goals of the international membership program is Liz Messner, Vice President of Membership at AANP. 

Randy Vawdrey, NP-C is the Chief Medical Officer for A Mind For All Seasons, which we discussed in episode 555 with co-founder Eric Collett,  and is board certified with the AANP! With 20 years of experience working and managing busy urgent care, family medicine, outpatient and inpatient mental health, weight loss, and hormone optimization practice, Randy has treated and improved the lives of thousands of patients. Since his graduation in 1998 from BYU in Nursing, Randy's career has blossomed into a focus on the identification and treatment of neuroinflammatory disorders. This includes treatment of traumatic brain injury (TBI), lingering symptoms from concussions, integrative treatments of mental health disorders, and the prevention and treatment of dementia.He has been the Program Director for Portneuf Valley Hospital's Gerontological Psychiatric Hospital. He has also served as the Director of the Psychotropic Drug Review at the Idaho State Veteran's Home and the CEO/NP-C at Physicians Immediate Care and Physicians Optimal Health. Randy has written over 1000 treatment plans addressing various forms of brain fog and neurodegenerative disorders. Find Randy at-https://www.amindforallseasons.com/https://randyvawdrey.com/Find Boundless Body at- myboundlessbody.com Book a session with us here!

Highlights of the JAANP issue topics: AANP research agenda, tribute to Dr. Loretta Ford, Empathic communication training, Geriatric NPs in Israel, Telehealth communication, POCUS training, Ethical opioid prescribing

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/identifying-and-managing-treatment-resistant-depression-9471Summary“Difficult-to-Treat” Depression (DTD) also referred as “treatment-resistant depression” (TRD) are two terms used interchangeably but with distinct implications for therapeutic decisions and treatment strategies. In addition to focusing on symptom control, interventions for difficult-to-treat depression (DTD) should also address other factors, such as managing psychiatric and medical comorbidities, however, erroneous diagnosis and lack of treatment adherence had led to a variety of DTD outcomes.In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Vladimir Maletic discuss the evolving neurologic basis of depression and empower clinicians with convergent evidence about the pathophysiology and appropriate treatment options of “difficult-to-treat depression” (DTD) and “treatment-resistant-depression” (TRD) to inform therapeutic decisions.This podcast/webcast was recorded and is being used with permission of the presenters.Learning ObjectivesUpon completion of this activity, learners should be able to: Review the evolving genetic and neurologic basis of depressionDistinguish between “difficult-to-treat” and “treatment-resistant” depression to inform therapeutic decisions, and appropriate treatment optionsThis activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which does includes 0.25 hours of pharmacology).For additional information about the accreditation of this program, contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is not commercially supported.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/complex-connections-of-psychiatric-comorbidities-9505SummaryThe clinical assessment of psychiatric comorbidities, emphasizes the importance of a comprehensive diagnostic evaluation and personalized treatment plan. The recognition of genetic factors and their implications, allows psychiatrists and clinicians to enhance their management of psychiatric comorbidities when facing individuals with multiple mental health challenges.In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Vladimir Maletic discuss the genetic underpinnings of mental health disorders and their psychiatric comorbidities, highlighting the role of heritability, genetic risk variants for depression, and polygenic burden in understanding complex psychiatric conditions. Dr. Maletic will delve into how genetic overlaps contribute to the co-occurrence of disorders such as anxiety and depression, and discuss the significance of gene-environment interactions and epigenetic changes in their development.This podcast was recorded and is being used with permission of the presenters.This activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which does not include hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is not commercially supported.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/exploring-the-depths-of-resilience-9449SummaryResilience, the ability to bounce back from adversity, is not solely determined by genetic factors but is heavily influenced by epigenetic mechanisms. Epigenetics can then influence DNA gene expression, playing a crucial role in shaping our resilience. It is known that while genetics provide a blueprint, our experiences and lifestyle choices can determine how those genes are expressed. However, neuroplasticity, the brain's remarkable ability to reorganize and adapt, underscores the potential for resilience to be cultivated and strengthened throughout life.In this podcast/webcast episode, Dr. Gregory Mattingly and Dr. Vladimir Maletic discuss the impact of resilience as well as strategies such as cognitive-behavioral therapy, exercise, social support networks, and healthy lifestyle habits which have been shown to promote neuroplasticity and enhance resilience by positively impacting epigenetic processes. By understanding and leveraging these interconnected concepts, individuals can empower themselves to navigate life's challenges with greater resilience and adaptability.This podcast was recorded and is being used with permission of the presenters.Learning ObjectivesUpon completion of this activity, learners should be able to: Summarize how trauma and resilience impact epigenetics and neuroplasticityDiscuss clinical interventions and strategies to improve resilience within your practiceThis activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which does not include any hours of pharmacology).For additional information about the accreditation of this program, contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is not commercially supported.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/how-to-manage-stress-mood-and-hormones-9448SummaryHormonal changes play a significant role in influencing mood and cognition. Fluctuations in hormone levels can impact neurotransmitter activity and neural circuits associated with mood regulation and cognitive function. For instance, during menstruation, pregnancy, menopause, and times of stress, hormone levels can fluctuate, leading to mood swings, irritability, anxiety, and cognitive changes.In this podcast/webcast episode, Dr. Gregory Mattingly and Dr. Vladimir Maletic discuss the impact of stress, hormones and mood, as understanding these hormonal influences is crucial for managing mood disorders, improving cognitive function, and promoting overall well-being.This podcast was recorded and is being used with permission of the presenters.Learning ObjectivesUpon completion of this activity, learners should be able to: Summarize the role of hormonal changes and their impact on mood and cognitionDiscuss recent developments that improve outcomes of hormonally triggered problems with mood or cognitionThis activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which does not include any hours of pharmacology).For additional information about the accreditation of this program, contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is not commercially supported.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Exocrine Pancreatic Insufficiency (EPI) is a condition caused by damage to the pancreas that results in reduced capability to produce or deliver digestive enzymes which break down fats, carbohydrates or proteins — or to a decrease in the enzyme activity in the small intestine. EPI is most commonly associated with chronic pancreatitis (in adults), cystic fibrosis (in children), diabetes (both type 1 and type 2) and other etiologies such as acute pancreatitis, pancreatic cancer or resection, celiac and Crohn's disease. Consequently, individuals with EPI may suffer malnutrition and fat-soluble vitamin deficiency; loss of bone mass; growth and immune deficiencies; and may experience poorer outcomes such as longer hospital stays and lower survival rates of underlying medical conditions secondary to malnutrition. Listen to guests Kimberly Kearns MS, APRN, ANP-BC and Amy Stewart FNP-C discuss EPI on this episode of the official podcast of the American Association of Nurse Practitioners® (AANP), NP Pulse: The Voice of the Nurse Practitioner® Additionally, two new tools are also available on AANP's Tools and Resources page in both the Gastroenterology and in the Pulmonology and Respiratory therapeutic areas: Pancreatic Enzyme Replacement Therapy (PERT) – Patient Guide to diet and lifestyle modifications, and to the self-administration of PERTs to help reduce symptoms including gas, bloating, abdominal pain and diarrhea caused by undigested food in the gut. Diagnosing and Managing Exocrine Pancreatic Insufficiency (EPI) – Provider Resource including evaluation of symptoms and common high-risk conditions, diagnostic testing and management goals combining diet, lifestyle and therapies to reduce symptoms and improve quality of life. Your voice counts here: EPI Podcast Follow Up Survey (surveymonkey.com)   **This podcast is unaccredited.  

For more information, visit https://thecirsgroup.com CIRS, or Chronic Inflammatory Response Syndrome, is an illness caused by mold and other biotoxins that affects 24% of the population and only a handful of doctors even know about it. We are so excited to have one of the greats on today: Dr. Eric Dorninger. Dr. D is a CIRS patient himself - he will share more about his and his family's health struggles, the reasons he fights for his patients' health, and the magic of healing from CIRS so we can be happy, healthy, kick ass individuals. For more information, support, and resources in your own CIRS healing journey, visit TheCIRSGroup.com TIME STAMPS: 0:00 Intro and disclaimer 1:18 Dr. Eric Dorninger's backstory 8:35 CIRSx and the Holy Trinity of CIRS Healing 9:18 BlueSkyCBD for mood disorders 10:10 Screening for CIRS 13:04 Story of patient healing from CIRS 14:59 Why your doctor's staff is so important 20:50 What it takes to work with CIRS patients 23:41 Tinnitus in CIRS patients 24:54 The problem with naming diseases 26:30 Dr. D's podcast The Vitality Hour 29:44 Patient Aaron Pettigrew's CIRS story 32:39 CIRSx and the importance of environment professionals 37:00 CIRS patients becoming CIRS practitioners 39:37 What the CIRS community should do to spread awareness 41:57 The problem with urinary mycotoxin tests and azoles 44:20 Endotoxin nuggets of wisdom 49:09 Outro and CIRSx excitement HELPFUL LINKS: Come to CIRSx! https://www.cirsx.com/ Dr. Dorninger's practice website: https://drdorninger.com/ Dr. Dorninger on AANP website: https://naturopathic.org/member/drdorninger BlueSkyCBD: https://www.bluesky-cbd.com/ Dr. D's podcast The Vitality Hour: https://www.youtube.com/channel/UCwmPARlXz7FIag_6NPS_uBg Vitality Hour on tolerating binders: https://youtu.be/omQL_mZrGRM?si=5DtyoM8E4i9I4qfU Take the CIRSx Courses: https://institute.cirsx.com/ The CIRS Group: Support Community: https://thecirsgroup.com Instagram: https://www.instagram.com/thecirsgroup/ Find Jacie for carnivore, lifestyle and limbic resources: Instagram: https://www.instagram.com/ladycarnivory YouTube: https://www.youtube.com/@LadyCarnivory Blog: https://www.ladycarnivory.com/ Limbic Training Community: https://www.wired4healing.com Find Barbara for business/finance tips and coaching: Website: https://www.actlikebarbara.com/ Instagram: https://www.instagram.com/actlikebarbara/ YouTube: https://www.youtube.com/@actlikebarbara Jacie is a 4 year carnivore, certified nutrition coach, and carnivore recipe developer determined to share the life changing information of carnivore and CIRS to anyone who will listen. Barbara is a coach, facilitator, speaker, 3 year carnivore, and a big fan of health and freedom. Together, they co-founded The CIRS Group, an online support community to help people that are struggling with their CIRS diagnosis and treatment. Catch Jacie and Barbara on Judy Cho's podcast to learn more about their health journeys and why they started The CIRS Group: When Carnivores are Affected by Mold Illness - Jacie Gregory & Barbara Williams - https://youtu.be/CR8Uj-d_fok

Many of us have questions after we step on a scale and see how much we weigh. How closely does that number correlate to our overall health? What is the best way, as nurse practitioners, to talk about weight with patients by emphasizing the positives of exercise and diet without reinforcing obesity bias? Today's guest on NP Pulse, AANP's new Vice President of Professional Practice Dr. Johnnie Sue Wijewardane, walks us through her personal weight loss journey and discusses the pros and cons of surgery, the very topical GLP-1s and even a fascinating aside into yo-yo trends like the “cabbage diet.” With her combination of expert analysis and trademark openness, Wijewardane guides us through the minefield of weight loss over-information into useful takeaways for both nurse practitioners and patients. For more resources on treating obesity and talking with patients about weight loss, visit aanp.org to find newsfeed articles and CE courses related to the topic. 

Credits: 0.50 AMA PRA Category 1 Credits™, 0.50 ABIM MOC or 0.56 AANP, including 0.56 AANP Pharm     CME/CE Information and Claim Credit: https://www.pri-med.com/online-cme-ce/podcast/practical-approaches-to-the-pharmacologic-treatment-of-obesity  Overview: In this podcast expert faculty will review the available options and discuss best practices for prescribing and monitoring long-term anti-obesity medications (AOM) as an important component of a chronic disease approach to obesity management. The discussion will include the indications, efficacy, safety, and adverse effects of currently FDA-approved AOM as well as the evidence supporting new agents like the GLP-1 receptor agonists and the newly approved dual GIP/GLP-1 receptor agonist tirzepatide. 

Credits: 0.25 AMA PRA Category 1 Credits™, 0.25 ABIM MOC or 0.35 AANP, including 0.17 AANP Pharm   CME/CE Information and Claim Credit: https://www.pri-med.com/online-cme-ce/Podcast/updates-changing-landscape-covid-19  Overview: Explore the evolving landscape of COVID-19 treatment in this brief podcast. Topics reviewed include updates to payments for antivirals, areas of clinician confusion around antiviral therapy use and managing drug interactions, the status of COVID-19 rebound, and long COVID. Stay informed to provide optimal patient care following the end of the COVID-19 public health emergency.  

How can health care providers like nurse practitioners help their male patients feel comfortable coming in for visits and discussing their most intimate issues — including but not limited to erectile dysfunction, low testosterone and more? Joining host Dr. Sophia Thomas on this episode of NP Pulse are Nick Cannone, associate medical director at Maze Men's Sexual and Reproductive Health, and AANP president Stephen Ferrara. Together, they talk all about men's health — and make a great case as to why men should be talking about their health, too.

Dr. Brady is also one of the foremost authorities on properly diagnosing and treating fibromyalgia, he has been featured in top popular media including Dr. Oz, ELLE and NPR. His latest Amazon best-selling book, The Fibro-Fix, was published by Rodale and released in July of 2016. In today's episode we discuss the complex topic of metabolomics, genomics and all the other omics. Dr. Brady will explain how this information can provide a way to analyze someone's unique physiology and personalize their care. What You Will Learn: 1. How Dr. Brady's passion for finding the answers to his mom's cancer diagnosis led him down non-conventional approaches. Today, Dr. Brady is an international expert in some of the hardest to treat chronic diseases, including fibromyalgia and Myalgia encephalomyelitis/Chronic fatigue syndrome (ME/CFS). 2. The power of the therapeutic relationship and the importance of a physician to be open- minded and seek solutions for their patient. 3. What “omics” medicine is and how it personalizes and tailors medicine. Dr. Brady reviews how it differs from diagnosing pathologies from traditional labs. 4. The difference between analyzing a gene variation, a SNP (single nucleotide polymorphism), such as MTHFR, in genomics and using metabolomics. 5. What is hypervigilance and how metabolomics can determine which are the best supplements to take based on various stress markers. 6. How essential oils can impact metabolomics and hypervigilance. 7. How essential oils are underutilized and understudied in functional and integrative medicine and why we should use them more for the full healing power they have. 8. The importance of “omic” testing and why one may want to consider it over just treating symptoms. 9. How to look for a reputable lab and why split sampling isn't the best way to assess the accuracy of a lab. 10. The Fibro-Fix book. 11. Dr. Brady's favorite oils (citrus) and how they uplift mood and can help with focus. 12. Closing Questions: What Dr. Brady does daily for self-care and what he thinks we should ditch and replace with instead. Bio of Dr. David M. Brady, ND, DC, CCN, DACBN, IFMCP, FACN Dr. David M. Brady has over 30-years of experience as an integrative medicine practitioner and 25 years in health sciences academia. He is a licensed naturopathic medical physician in Connecticut and Vermont, is board certified in functional medicine and clinical nutrition, and a fellow of the American College of Nutrition. Dr. Brady is the Chief Medical Officer for Diagnostic Solutions Labs, LLC and Designs for Health, Inc. He is currently in private practice in the integrative medicine group Whole Body Medicine, in Fairfield, CT (USA). Dr. Brady is the former long-term vice president of the Division of Health Sciences and director of the Human Nutrition Institute at the University of Bridgeport in Connecticut, where he continues to serve as director and professor emeritus of nutrition. He has appeared on the plenary speaking panel of some of the largest and most prestigious conferences in the field including IFM, ACAM, A4M, ACN, IHS, AANP, AIHM and many more. Dr. Brady has published a multitude of peer-reviewed scientific papers and textbooks related to functional and naturopathic medicine, clinical nutrition, chronic pain, autoimmunity, and functional gastroenterology. Links to learn more about Dr. Brady, his companies, and offerings: Dr. David M. Brady  Chief Medical Officer, Designs for Health, Inc. & Diagnostic Solutions Lab, LLC Director Emeritus, Nutrition Institute & Associate Professor of Clinical Sciences, University of Bridgeport Private Clinical Practice, Whole Body Medicine (Fairfield, CT-USA) Author of The Fibro-Fix Dr. Brady on Facebook Designs for Health Video Dr. Brady's Presentation: Anxiety, Depression, and Stress: A Multi-Omics Approach Dr. Brady's Articles and Publications Learn more about your ad choices. Visit megaphone.fm/adchoices